BobbyAxelrod

BobbyAxelrod | Joined since 2020-08-03

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

73

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
73
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2020-08-11 16:36 | Report Abuse

one way to average down is by acquiring its warrant AT-WC 1:1 and relatively cheap circa 8sen to 8.5sen now

Stock

2020-08-11 14:38 | Report Abuse

Most banks have upgraded TP for all gloves stocks. Let's fly with AT

Stock

2020-08-11 10:56 | Report Abuse

".. pointed out that existing players would not have embarked on the expansion path if they had not done the necessary calculations to derive what future demand would look like. For the next one to two years, demand will be there owing to new norms surrounding the Covid-19 pandemic. The glove manufacturers would have done their homework to justify the expansions. Furthermore, there is a shift in the demand curve for rubber gloves, projecting the consumption to be higher than before even when the demand normalises."

https://www.theedgemarkets.com/article/expansion-rush-concern-rubber-glove-glut-valid

Stock

2020-08-11 10:55 | Report Abuse

".. pointed out that existing players would not have embarked on the expansion path if they had not done the necessary calculations to derive what future demand would look like. For the next one to two years, demand will be there owing to new norms surrounding the Covid-19 pandemic. The glove manufacturers would have done their homework to justify the expansions. Furthermore, there is a shift in the demand curve for rubber gloves, projecting the consumption to be higher than before even when the demand normalises."

https://www.theedgemarkets.com/article/expansion-rush-concern-rubber-glove-glut-valid

Stock

2020-08-11 10:46 | Report Abuse

Zoom out a little bit fellow investors, those who bought in June already getting more than 120%; the stocks are in the uptrend and the fundamentals are solid. Gloves will continue to persist as absolute necessities in the new norm even when vaccine is ready.

Stock

2020-08-11 10:45 | Report Abuse

Zoom out a little bit fellow investors, those who bought in June already getting more than 120%; the stocks are in the uptrend and the fundamentals are solid. Gloves will continue to persist as absolute necessities in the new norm even when vaccine is ready.

Stock

2020-08-11 10:18 | Report Abuse

with 1:1 to mother, this warrant is very attractive. let's accumulate big lots now at 9-10sen.. once more development for this project announced, we'll ride to the institutionals' TP

Stock

2020-08-11 10:17 | Report Abuse

let's accumulate big lots now at 13-14sen.. once more development for this project announced, we'll ride to the institutionals' TP

Stock

2020-08-11 09:41 | Report Abuse

The cheapest glove stocks with future 928 million pieces of rubber gloves per year production by Nov2020 - Apr2021

Stock

2020-08-11 09:41 | Report Abuse

The cheapest glove stocks with future 928 million pieces of rubber gloves per year production by Nov2020 - Apr2021

Stock

2020-08-10 14:28 | Report Abuse

continuous big blocks of buying since 9am..

Stock
Stock

2020-08-10 13:47 | Report Abuse

Sinopharm Group Co Ltd is there and among the front-runners for Covid Vaccine:
https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker

Stock

2020-08-10 11:54 | Report Abuse

China's Sinopharm to test potential Covid-19 vaccine in Brazil
Thursday, 30 Jul 2020 08:37 AM MYT

The company logo of Sinopharm Group Co Ltd is displayed at a news conference on the company's annual results in Hong Kong March 29, 2016. — Reuters pic
The company logo of Sinopharm Group Co Ltd is displayed at a news conference on the company's annual results in Hong Kong March 29, 2016. — Reuters pic
RIO DE JANEIRO, July 30 — Chinese drug company Sinopharm and Parana state have agreed to launch the fourth major Covid-19 vaccine trial in Brazil and will seek regulatory approval in the next two weeks, the Brazilian partners said yesterday.

A trial by Sinopharm would join Phase III trials already announced in Brazil by AstraZeneca, Sinovac Biotech and a Pfizer partnership with BioNTech.


Jorge Callado, head of the Parana Technology Institute (Tecpar), said they would soon finalize their proposal and submit it for approval with federal health regulator Anvisa.

Brazil's Covid-19 outbreak, the world's worst outside the United States, has made it global testing ground for potential vaccines.


Sinopharm's candidate vaccine is already being tested in the United Arab Emirates with 15,000 volunteers.


Parana is also in talks with Russian researchers about producing their potential vaccine, the state government said in a statement, adding that Governor Ratinho Júnior would soon meet with Russia's ambassador to Brazil.

Russians have also contacted Sao Paulo's Butantan Institute to discuss testing their vaccine, the institute's director told reporters on Wednesday. — Reuters

Stock

2020-08-10 10:11 | Report Abuse

Seeing the mothershare is on the way beyond RM1 with the linkage to SINOPHARM and the vaccine development news, this TITIJYA-PA warrant looks like a very lucrative deal

Stock

2020-08-10 10:07 | Report Abuse

Seeing the mothershare is on the way beyond RM1 with the linkage to SINOPHARM and the vaccine development news, this warrant looks like a very lucrative deal

Stock

2020-08-10 09:50 | Report Abuse

TITIJYA-PA the warrant for this TITIJYA looks promising too

Stock

2020-08-07 12:24 | Report Abuse

at this rate, TITIJYA-PA also looks promising for a vehicle

Stock

2020-08-07 11:41 | Report Abuse

from the buy queue, since 9am this morning, continuous big blocks of buying. SINOPHARM - TITIJYA is brewing?

Stock

2020-08-06 14:35 | Report Abuse

KUALA LUMPUR (Aug 6): Serba Dinamik Holdings Bhd said today its wholly-owned subsidiary Serba Dinamik International Ltd (SDIL) had yesterday (Aug 5) accepted a letter of award from Future Digital Data Systems LLC (FDDS) to build a data centre for US$350 million (about RM1.47 billion).

In a statement to Bursa Malaysia today, Serba Dinamik said the project will be built at Mussaffah, Abu Dhabi.

"The project forms part of FDDS’s initiatives to develop (a) series of data centres across the Middle East and North Africa (MENA) region, that will support the activities in Abu Dhabi and also provide services to the rest of the Gulf Corporation Council (GCC), to address the growing need in the market, due to the emergence of Cloud, Artificial Intelligence, Machine Learning, Internet of Things (IoT) and Big Data Analytics.

"FDDS intends to build a new data centre that can host mission critical systems and provide colocation services, business continuity and managed services facilities to local and international organisations,” Serba Dinamik said.

Serba Dinamik said the project’s work scope includes the appointment of specialist consultants and contractors to undertake the management, design, procurement, construction, and completion segments of the project.

"The award is conditional on finalisation and execution of contract documents and both parties agreeing to the effective date of the works as of Sept 1, 2020 (commencement date).

"The company shall complete the works within 1,460 days from the commencement date,” Serba Dinamik said.

At Bursa’s 12:30pm break today, Serba Dinamik’s share price settled up six sen or 3.66% at RM1.70 for a market value of about RM5.73 billion. The stock saw some 11 million shares traded.

Stock

2020-08-05 10:38 | Report Abuse

sharks in full swing mode for OPCOM

Stock

2020-08-04 16:07 | Report Abuse

the tripartite should move & closely correlate with each other: KOSSAN & GOCEAN already moving up

Stock

2020-08-04 15:56 | Report Abuse

the tripartite should move & closely correlate with each other: KOSSAN & GOCEAN already moving up